Kaio Maciel de Santiago-Silva

6PUBLICATIONS
26CO-AUTHORS
Biomolecular modelling and designPharmacogenomicsComputational chemistryBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 14, 2024
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro.

Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa Esteves Carvalho Constant

|Jul 20, 2023
Proteasome as a Drug Target in Trypanosomatid Diseases.

Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, Marciéli Fabris

|Nov 03, 2022
In silico approaches and in vitro assays identify a coumarin derivative as antiviral potential against SARS-CoV-2.

Gabriel Felix da Silva Gomes, Priscila Goes Camargo, Kaio Maciel de Santiago-Silva

|Oct 27, 2022
Antileishmanial Activity of 4,8-Dimethoxynaphthalenyl Chalcones on Leishmania amazonensis.

Kaio Maciel de Santiago-Silva, Bruna Taciane da Silva Bortoleti, Laudicéa do Nascimento Oliveira

|Sep 20, 2022
In silico approach identified benzoylguanidines as SARS-CoV-2 main protease (Mpro) potential inhibitors.

Kaio Maciel de Santiago-Silva, Priscila Camargo, Gabriel Felix da Silva Gomes

|Aug 06, 2021
Exploring the antileishmanial activity of N1,N2-disubstituted-benzoylguanidines: synthesis and molecular modeling studies.

Kaio Maciel de Santiago-Silva, Bruna Taciane da Silva Bortoleti, Tiago de Oliveira Brito

Pageof 1

Frequent Collaborators

5 joint publications

Camilo Henrique da Silva Lima

5 joint publications

Marcelle de Lima Ferreira Bispo

4 joint publications

Priscila Goes Camargo

3 joint publications

Gerson Nakazato